Sawai Group Holdings Co., Ltd. (TYO:4887)
1,960.50
+11.00 (0.56%)
Aug 1, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Circulatory System Drugs | 42.14B | Log In | Log In | Log In | Log In | Upgrade |
Circulatory System Drugs Growth | -14.24% | Log In | Log In | Log In | Log In | Upgrade |
Central Nervous System Drugs | 24.57B | Log In | Log In | Log In | Log In | Upgrade |
Central Nervous System Drugs Growth | -41.70% | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Drugs | 19.09B | Log In | Log In | Log In | Log In | Upgrade |
Digestive System Drugs Growth | 3.99% | Log In | Log In | Log In | Log In | Upgrade |
Other Metabolic Drugs | 18.15B | Log In | Log In | Log In | Log In | Upgrade |
Other Metabolic Drugs Growth | 14.65% | Log In | Log In | Log In | Log In | Upgrade |
Blood and Body Fluid Drugs | 16.01B | Log In | Log In | Log In | Log In | Upgrade |
Blood and Body Fluid Drugs Growth | -2.66% | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics | 9.27B | Log In | Log In | Log In | Log In | Upgrade |
Antibiotics Growth | 15.39% | Log In | Log In | Log In | Log In | Upgrade |
Vitamins | 7.36B | Log In | Log In | Log In | Log In | Upgrade |
Vitamins Growth | -0.85% | Log In | Log In | Log In | Log In | Upgrade |
Allergy Drugs | 6.95B | Log In | Log In | Log In | Log In | Upgrade |
Allergy Drugs Growth | 6.58% | Log In | Log In | Log In | Log In | Upgrade |
Oncology Drugs | 6.10B | Log In | Log In | Log In | Log In | Upgrade |
Other | 27.23B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -10.47% | Log In | Log In | Log In | Log In | Upgrade |
Urinogenital and Anal Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Urinogenital and Anal Drugs Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Chemotherapy Drugs | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 | 2016 - 2018 |
Japan | 176.86B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | 8.04% | Log In | Log In | Log In | Log In | Upgrade |
United States | - | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | - | Log In | Log In | Log In | Log In | Upgrade |